Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Predictive Oncology Inc POAI

Healthcare Medical Devices
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence (AI) to support the development of cancer therapies. The Company operates through three segments: Pittsburgh, Birmingham, and Eagan. Pittsburgh segment provides services, which include the application of artificial intelligence (AI) using its proprietary biobank of 150,000 plus tumor samples... see more

Recent & Breaking News (NDAQ:POAI)

Precision Therapeutics’ TumorGenesis Division Isolates Discovery Biomarkers for Thyroid Cancer Cell Types, Initiating Its Proprietary Process for New Drug Development Via Patient-Derived Tumor Models

GlobeNewswire February 5, 2019

Precision Therapeutics’ Skyline Medical Division Widens Global Reach Through New Taiwanese Distribution Agreement with Winner Scientific

GlobeNewswire January 25, 2019

Precision Therapeutics Has Groundbreaking Approach to Personalized Cancer Treatment, Reports CEOCFO Magazine

Accesswire January 22, 2019

Precision Therapeutics Receives $1,370,000 Investment from CEO and Director, Carl Schwartz

GlobeNewswire January 18, 2019

Precision Therapeutics’ Skyline Medical Division Significantly Expands Footprint in New England With Sale of Six STREAMWAY Systems to Yale University Ambulatory Outpatient Surgical Center

GlobeNewswire January 17, 2019

Precision Therapeutics Reports Third Quarter 2018 Financial Results

GlobeNewswire November 14, 2018

Helomics Corp Partners with UK 100,000 Genomes Project to Drive its Artificial Intelligence-Powered Precision Oncology Platform for Ovarian Cancer

GlobeNewswire November 14, 2018

Precision Therapeutics to Hold Business Update Conference Call on November 14, 2018

GlobeNewswire November 8, 2018

Precision Therapeutics Secures Rights to Novel Technology Designed To Develop Drugs That Target Specific Cancer by Its Mutation

GlobeNewswire November 7, 2018

Precision Therapeutics’ CEO Talks with Uptick Newswire’s Stock Day Podcast About Exciting New Breakthroughs in Tumor Treatment and What’s on the Horizon

GlobeNewswire November 5, 2018

Filing under Rule 425 under the Securities Act of 1933 and deemed filed under Rule 14a-12 of the Securities Exchange Act of 1934 Filing by: Precision Therapeutics Inc.: SEC File Nos. 001-36790; and 333-221966

GlobeNewswire October 29, 2018

Precision Therapeutics Continues to Build World Class Scientific Advisory Board with Appointment of Hector J. Gomez, MD, PhD

GlobeNewswire October 11, 2018

Precision Therapeutics’ Skyline Medical Division Signs International Distribution Agreement with India-based Prenit World

GlobeNewswire October 9, 2018

Precision Therapeutics Secures First STREAMWAY System Sale in Europe

GlobeNewswire September 27, 2018

Dr. Bob Murphy, Head of Computational Biology at Carnegie Mellon University, Joins Precision Therapeutics’ Scientific Advisory Board

GlobeNewswire September 25, 2018

Precision Therapeutics Bolsters Scientific Advisory Board with the Appointment of Dr. Paul Kornblith

GlobeNewswire September 13, 2018

Precision Therapeutics Appoints Dr. Amelia Warner to Scientific Advisory Board

GlobeNewswire September 11, 2018

Precision Therapeutics Forms Scientific Advisory Board to Advance its Strategy in the Precision Medicine Sector

GlobeNewswire September 6, 2018

Precision Therapeutics Reports Second Quarter 2018 Financial Results

GlobeNewswire August 14, 2018

Precision Therapeutics Investee, Helomics Corporation, Announces Commercial Launch of New ‘HelomicsDiscover’ Program to Drive Forward the Next Generation of Precision Cancer Therapies

GlobeNewswire August 14, 2018